Repare Therapeutics Shareholders May be Entitled to Additional Compensation for Sale to XenoTherapeutics

Halper Sadeh LLC is investigating whether the sale of Repare Therapeutics Inc. to XenoTherapeutics is fair to Repare shareholders. The proposed transaction will result in a cash payment of $1.82 per share plus contingent value rights. Halper Sadeh encourages Repare shareholders to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [info@halpersadeh.com](mailto:info@halpersadeh.com). The investigation concerns whether Repare and its board of directors violated federal securities laws and/or breached fiduciary duties.